Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 240 Lymphoma 232 Lymphoma, Non-Hodgkin 205 Leukemia, Lymphocytic, Chronic, B-Cell 184 Lymphoma, Large B-Cell, Diffuse 177 Lymphoma, Follicular 172 Lymphoma, B-Cell 112 Lymphoma, Mantle-Cell 106 Hodgkin Disease 105 Leukemia, Myeloid, Acute 101 Recurrence 98 Multiple Myeloma 92 Burkitt Lymphoma 90 Leukemia 78 Neoplasms 68 Lymphoma, B-Cell, Marginal Zone 59 Hematologic Neoplasms 59 Myelodysplastic Syndromes 56 Waldenstrom Macroglobulinemia 47 Lymphoma, T-Cell 43 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 41 Lymphoma, T-Cell, Peripheral 36 Lymphoma, T-Cell, Cutaneous 31 Leukemia, Biphenotypic, Acute 30 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29 Leukemia, B-Cell 27 Mycosis Fungoides 25 Lymphoma, Large-Cell, Anaplastic 25 Sarcoma 24 Breast Neoplasms 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Large B-cell Lymphoma × Lymphoid × 90 days × Clear all

NCT07215585 2026-05-22

SOUNDTRACK-D2

AstraZeneca

Phase 3 Recruiting

Large B-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡